WENDY MC BUI
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant AURORA, CO NPI 1780141895
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant CO Antares Pharma, Inc. All categories
General Payments — all program years on this page
$4,246.77
- Category: General Payments
- Program years: PY2021–2024
- Record count: 224
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,038.71 across 99 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,038.71 | 99 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Antares Pharma, Inc. | $417.31 | 37 |
| CeQur Corporation | $262.06 | 1 |
| Amgen Inc. | $205.39 | 6 |
| Amneal Pharmaceuticals LLC | $198.16 | 10 |
| Lilly USA, LLC | $155.25 | 10 |
| Amphastar Pharmaceuticals, Inc. | $105.15 | 2 |
| Medtronic, Inc. | $70.96 | 4 |
| Novo Nordisk AS | $59.86 | 3 |
| ABBVIE INC. | $51.67 | 3 |
| RECORDATI_RARE_DISEASES_INC. | $47.00 | 2 |
| Alexion Pharmaceuticals, Inc. | $43.18 | 1 |
| Radius Health, Inc. | $41.46 | 2 |
| SANOFI-AVENTIS U.S. LLC | $39.44 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $38.70 | 2 |
| Ascendis Pharma Inc | $35.36 | 2 |
| Tandem Diabetes Care, Inc. | $32.14 | 1 |
| Alvogen Inc | $30.74 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $29.65 | 1 |
| BETA BIONICS, INC. | $26.21 | 1 |
| IBSA Pharma Inc. | $25.56 | 1 |
| DEXCOM, INC. | $21.47 | 1 |
| MannKind Corporation | $21.19 | 1 |
| Xeris Pharmaceuticals, Inc. | $17.54 | 1 |
| Ascensia Diabetes Care US Inc. | $17.14 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.82 | 1 |
| PFIZER INC. | $15.29 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.01 | 1 |
By program year
Records — PY2024 (99)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.